Nucleoside Cell Factory Synthesis Service

Advantages of Cell Factory for Nucleoside Synthesis

The fusion of a nitrogenous base with a sugar moiety, usually ribose or deoxyribose, is used in the production of nucleosides. This fusion can occur spontaneously within cells during nucleotide biosynthesis or in a laboratory. Enzymes aid in the synthesis of nucleosides by catalyzing the glycosidic connection between the nitrogenous base and the sugar. Chemical procedures can be used in the laboratory to synthesize nucleosides. Uridine, a pyrimidine nucleoside, is widely used in the pharmaceutical industry. A recent research emphasis is on uracil cell factory manufacturing, with CRISPR/Cas9-mediated chromosomal integration functioning as an effective technique for developing appropriate cell factories for this purpose.

The biosynthetic pathway of uridine in E. coli and the scheme for construction of the uridine production strain.Fig.1 The biosynthetic pathway of uridine in E. coli and the scheme for construction of the uridine production strain. (Wu, et al., 2018).

Nucleoside Cell Factory Synthesis Service at CD BioGlyco

Nucleosides and nucleoside derivatives, integral components of antiviral and anticancer medications, are often synthesized using Chemical Methods. However, this approach involves hazardous compounds, leading to environmental harm. Enzymatic synthesis, like the production of 5-methyluridine, is an alternative, but bacterial cell requirements limit its scalability. Cell factories offer a novel avenue for nucleoside manufacturing. Leveraging our robust experimental platform, CD BioGlyco employs recombinant bacteria with potent nucleoside-producing enzymes for cell factory-based nucleoside and analog production. Our services encompass the Technology Development Phase and scalable production, ensuring clients' needs are met. We also extend Nucleotide Synthesis Services, including Chemical Synthesis, Microbial Synthesis, and Enzymatic Digestion, ensuring comprehensive support for diverse research and industrial applications.

It is critical to emphasize that the success of nucleoside synthesis utilizing a cell factory is dependent on meticulous strain engineering, growth environment optimization, and efficient metabolic pathway design. Furthermore, sophisticated techniques like CRISPR/Cas9-Mediated Genome Editing can aid in the construction of high-yielding cell factories for nucleoside manufacturing.

Standard nucleoside cell factory synthesis process.Fig.2 Standard nucleoside cell factory synthesis process. (CD BioGlyco)

Applications

  • Nucleosides are essential components of DNA and RNA, making them crucial for developing antiviral, anticancer, and antifungal drugs. Cell factories can produce nucleosides that serve as precursors for these pharmaceuticals.
  • Nucleosides are used in diagnostic tests, such as the polymerase chain reaction (PCR), for amplifying and detecting DNA or RNA sequences. Cell factories can produce nucleosides used as substrates in such assays.
  • Nucleosides are used in the production of recombinant proteins and monoclonal antibodies. Nucleoside synthesis in cell factories can support these processes by providing essential building blocks.
  • Nucleosides are widely used as research tools in various biological studies, including molecular biology and genetics. Cell factory-produced nucleosides can provide researchers with a convenient and cost-effective source.

Advantages

  • We offer custom engineering strain development services for our clients according to their needs, which is a preparation for the cell factory synthesis services.
  • We employ a good lab team that offers high-quality production outcomes.
  • Our service team consistently provides exceptional client support, offering prompt and helpful assistance to address client needs and inquiries.

CD BioGlyco provides cell factory synthesis services for synthesizing nucleosides, and we have a high-level lab to process high-quality synthesis experiments. Please feel free to contact us for more detailed information.

Reference

  1. Wu, H.; et al. Metabolic engineering of Escherichia coli for high-yield uridine production. Metabolic Engineering. 2018, 49: 248–256.
This service is for Research Use Only, not intended for any clinical use.

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.